Publications

5674 Results

Recurrence score and clinicopathologic characteristics of TAILORx participants by race and ethnicity

Authors
M Zlobinsky Rubinstein;RJ Gray;J Sparano;J Zujewski;T Whelan;KS Albain;D Hayes;CE Geyer;EC Dees;EA Perez;M Keane;C Vallejos;T Goggins;I Mayer;A Brufsky;D Toppmeyer;V Kaklamani;J Atkins;J Berenberg;J Sledge
Journal / Conference
Journal of Clinical Oncology 33:5s (suppl; abstr 533); American Society of Clinical Oncology Annual Meeting (May 29-June 2, 2015, Chicago, IL), poster session;
Year
2015
Research Committee(s)
Breast

Impact of neoadjuvant therapy on breast conservation rates in triple- negative and HER2-positive breast cancer: combined results of CALGB 40603 and 40601 (Alliance)

Authors
M Golshan;C Cirrincione;D Berry;L Carey;W Sikov;N Henry;G Somlo;E Port;E Winer;C Hudis;D Ollila
Journal / Conference
Journal of Clinical Oncology 33:5s (suppl; abstr 1007); American Society of Clinical Oncology Annual Meeting (May 29-June 2, 2015, Chicago, IL), oral;
Year
2015
Research Committee(s)
Breast
Study Number(s)
CTSU/C40603

Lung Master Protocol (Lung-MAP) biomarker-driven protocol for accelerating development of therapies for squamous cell lung cancer: SWOG S1400

Authors
R Herbst;D Gandara;F Hirsch;M Redman;M LeBlanc;PC Mack;L Schwartz;E Vokes;S Ramalingam;JD Bradley;D Sparks;H Zhou;C Miwa;VA Miller;R Yelensky;Y Li;JD Allen;EV Sigal;D Wholley;CC Sigman;G Blumenthal;S Malik;G Kelloff;J Abrams;C Blanke;V Papadimitrakopoulou
Journal / Conference
Clinical Cancer Research, Apr 1;21(7):1514-1524
Year
2015
Research Committee(s)
Lung
PMID
PMID25680375
PMC
PMC4654466
Study Number(s)
S1400

Four genes predict high risk of progression from smoldering to symptomatic multiple myeloma (SWOG S0120)

Authors
R Khan;MV Dhodapkar;A Rosenthal;C Heuck;X Papanikolaou;P Qu;F van Rhee;M Zangari;Y Jethava;J Epstein;S Yaccoby;J Crowley;N Petty;C Bailey;G Morgan;B Barlogie
Journal / Conference
Haematologica Sep;100(9):1214-1221
Year
2015
Research Committee(s)
Myeloma
PMID
PMID26022710
PMC
PMC4800692
Study Number(s)
S0120

Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis

Authors
P Blanchard;A Lee;S Marguet;J Leclercq;WT Ng;J Ma;A Chan;P-Y Huang;E Benhamou;G Zhu;D Chua;Y Chen;H-Q Mai;D Kwong;SL Cheah;J Moon;Y Tung;K-H Chi;G Fountzilas;L Zhang;M Hareyama;EP Hui;T-X Lu;J Bourhis;J-P Pignon
Journal / Conference
Lancet Oncology Jun;16(6):645-655
Year
2015
Research Committee(s)
Early Therapeutics and Rare Cancers and Head and Neck
PMID
PMID25957714
PMC
n/a
Study Number(s)
SWOG-8892 (INT-0099) (EST-2388) (RTOG-8817)

Radiation use and field design in women with node positive breast cancer treated with preoperative systemic therapy and breast surgery including axillary dissection on a prospective clinical trial ACOSOG Z1071 [Alliance]

Authors
BG Haffty;LM McCall;KV Ballman;S McLaughlin;R Jagsi;DW Ollila;K Hunt;TA Buchholz;JC Boughey
Journal / Conference
International Journal of Radiation Oncology, Biology, Physics Nov 93(3):Supplement S136, Abst. 310; ASTRO Annual Meeting (October 18-21, 2015, San Antonio, TX), oral presentation;
Year
2015
Research Committee(s)
Breast

Long-term follow-up of the E1199 phase III trial evaluating the role of taxane and schedule in operable breast cancer

Authors
J Sparano;F Zhao;S Martino;J Ligibel;EA Perez;T Saphner;AC Wolff;G Sledge;W Wood;NE Davidson
Journal / Conference
Journal of Clinical Oncology Jul 20;33(21):2353-2360
Year
2015
Research Committee(s)
Breast
PMID
PMID26077235
PMC
PMC4500829
Study Number(s)
E1199

Phase 1 Trial of G-CSF, cladribine, cytarabine, and dose-escalated mitoxantrone (G-CLAM) in adults with newly diagnosed AML or high-risk MDS

Authors
A Anwar;A Halpern;BL Scott;PS Becker;M Othus;PC Hendrie;EM Ranker;A Perdue;TL Chen;SA Buckley;KF Orlowski;MA Powell;E Estey;RB Walter
Journal / Conference
European Hematology Association Annual Meeting (June 11-14, 2015, Vienna, Austria), poster;
Year
2015
Research Committee(s)
Leukemia
Study Number(s)
S0106

Methods to standardize a multicenter acupuncture trial protocol to reduce aromatase inhibitor-related joint symptoms in breast cancer patients

Authors
H Greenlee;K Crew;J Capodice;D Awad;A Jeffres;J Unger;D Lew;L Hansen;FL Meyskens;JL Wade;DL Hershman
Journal / Conference
Journal of Acupuncture and Meridian Studies Jun;8(3):152-158
Year
2015
Research Committee(s)
Symptom Management and Survivorship
PMID
PMID26100070
PMC
PMC4705910
Study Number(s)
S1200

Prospective analysis of antigen-specific immunity, stem cell antigens and immune checkpoints in monoclonal gammopathy

Authors
M Dhodapkar;R Sexton;R Das;L Zhang;R Sundaram;S Soni;J Crowley;RZ Orlowski;B Barlogie
Journal / Conference
Blood, Nov 26;126(22):2475-2478
Year
2015
Research Committee(s)
Myeloma
PMID
PMID26468228
PMC
PMC4661169
Study Number(s)
S0120